Asthma costs and utilization in a managed care organization.
Explore this paper's citation graph
Summary
Total direct costs and asthma-related utilizations are meaningfully less in the year after being dispensed single controller ICS compared with single controller leukotriene modifiers or most combination controllers.
- Type
- article
- Published
- 2008-04-01
- Cited by
- 41
- References
- 36
- Access
- Open access
- OpenAlex
- https://openalex.org/W2059129196
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31860760
Keywords
Asthma, Medicine, Medical prescription, Medicaid, Health care
References
- Asthma population management: development and validation of a practical 3-level risk stratification scheme.
- Salmeterol/Fluticasone Propionate versus Fluticasone Propionate Plus Montelukast
- Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
- Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.
- Smearing Estimate: A Nonparametric Retransformation Method
- Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model
- Asthma‐Related Health Care Resource Use Among Patients Starting Fluticasone or Montelukast Therapy
- Cochrane review: Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma
- No Adjustments Are Needed for Multiple Comparisons
- A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
- Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
- Determinants of future long-term asthma control.
- The health economics of asthma and rhinitis. I. Assessing the economic impact.
- The Prevalence of Reversible Airflow Obstruction and/or Methacholine Hyperreactivity in Random Adult Asthma Patients Identified by Administrative Data
- Using Risk-Adjustment Models to Identify High-Cost Risks
- Economic Impact of Asthma Therapy with Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population
- Outcomes Associated with Initiation of Different Controller Therapies in a Medicaid Asthmatic Population: A Retrospective Data Analysis
- Resource utilization in asthma:combined fluticasone propionate/salmeterol compared with inhaled corticosteroids
- Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
- Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone*
Cited by
- A Review of Electronic Devices to Assess Inhaler Technique
- Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting.
- High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
- Impact of asthma controller medications on clinical, economic, and patient-reported outcomes.
- Asthma in the Elderly: Current Understanding and Future Research Needs
- Inhaled corticosteroids in lung diseases.
- Healthcare utilization and expenditures for low income children with sickle cell disease
- Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
- Particle size of inhaled corticosteroids: does it matter?
- Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.
- Asthma in Pediatric Patients: Unmet Need and Therapeutic Options
- Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) study.
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
- The misuse of asthma drugs
- Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.
- Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study.
- Advances in pediatric asthma in 2008: where do we go now?
- Advances in Adult Asthma Diagnosis & Treatment and HCEDQ in 2008
- Improving asthma outcomes in large populations.
- Planning for Action: The Impact of an Asthma Action Plan Decision Support Tool Integrated into an Electronic Health Record (EHR) at a Large Health Care System
Related papers
- Homelessness and Medicaid Churn.
- Impacts of Early ACA Medicaid Expansions on Physician Participation.
- Previous Medicaid Status of Children Newly Enrolled in Supplemental Security Income
- Medicaid Expansions and Access to Substance Abuse Treatment Services Among Limited English Proficiency Populations
- The Impact of Medicaid Expansion on Continuous Enrollment: a Two-State Analysis
- Trends in Physician Participation in Medicaid
- Trends in pediatric hospitalizations of children in washington state by insurance and chronic condition status, 1991-1998.
- Physician Participation in Medicaid Revisited